
ir.armstrong.com
Investors - Armstrong World Industries IncThe Investor Relations website contains information about Armstrong World Industries Inc business for stockholders, potential investors, and financial analysts.
http://ir.armstrong.com/
The Investor Relations website contains information about Armstrong World Industries Inc business for stockholders, potential investors, and financial analysts.
http://ir.armstrong.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
0.5 seconds
PAGES IN
THIS WEBSITE
0
SSL
EXTERNAL LINKS
6
SITE IP
206.200.251.19
LOAD TIME
0.484 sec
SCORE
6.2
Investors - Armstrong World Industries Inc | ir.armstrong.com Reviews
https://ir.armstrong.com
The Investor Relations website contains information about Armstrong World Industries Inc business for stockholders, potential investors, and financial analysts.
ARCTREIT.COM
Investor Relations - Ardelyx
Non-Systemic Therapies, Reduced Risk. Annual Reports and Proxies. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Ardelyxs financial performance into perspective. 070 ( 3.84%). 4:00 PM ET on August 14, 2015. Delayed at least 20 minutes. August 12, 2015. Ardelyx Reports Second Quarter 2015 Financial Results. August 5, 2015. Ardelyx to Report Second Quarter 2015 Financial Results on August 12, 2015.
Investors – Argos Therapeutics
Platform & Pipeline. Platform & Pipeline. Aug 14, 2015 at 4:00 PM ET. Intraday data provided by eSignal. Press Releases View all. Argos Therapeutics Reports Second Quarter 2015 Financial Results and Operational Highlights. Argos Therapeutics Announces Pilot Clinical Trial of AGS-003 as Neoadjuvant Immunotherapy for Localized Renal Cell Carcinoma. Events and Presentations View all. May 14, 2015 at 4:30 PM ET. Argos Therapeutics, Inc. First Quarter 2015 Financial Results Conference Call.
ARM Holdings - Investor Relations - ARM Holdings plc - ARM Holdings plc - Investors
This site uses cookies to store information on your computer. By continuing to use our site, you consent to our cookies. PLEASE NOTE: If you have adjusted your cookie settings on www.arm.com. These settings do not apply to this website. ARM websites use two types of cookie: ( 1). Those that enable the site to function and perform as required; and (2). To learn how they can be disabled. By disabling cookies some features of the site will not work. Accept and hide this message. Mali Cost Efficient Graphics.
IR Overview | Armada
Back to the Corporate Site. Armada Hoffler Properties to Discuss Fourth Quarter Earnings on February 9th. Armada Hoffler Properties Announces Retail Acquisitions in North Carolina and Virginia. Armada Hoffler Properties Added to the MSCI U.S. REIT Index (RMZ). Armada Hoffler Properties Announces Its Fourth Quarter 2016 Cash Dividend. Armada Hoffler Properties Reports Third Quarter 2016 Results. S&P Global Market Intelligence. TERMS AND CONDITIONS OF USE. These Terms of Use are the entire agreement betwee...
Investors - Armstrong World Industries Inc
Annual Reports and Proxies. Archived and Upcoming Events. Disclosure Policy and Quiet Periods. Annual Reports and Proxies. Archived and Upcoming Events. Disclosure Policy and Quiet Periods. Day High: 58.84. Day Low: 57.64. Aug 14, 2015. Delayed 20 min., by eSignal. Thomas J. Waters. Vice President, Treasury, and Investor Relations. Armstrong World Industries, Inc. Kristy Olshan, CPA, MBA. 717) 396-6354 ksolshan@armstrong.com. Jul 30, 2015. Armstrong World Industries Reports Second Quarter 2015 Results.
Armstrong Coal | Investors Welcome Page
Get News Alerts by Email. Safety and The Environment. Get News Alerts by Email. Armstrong is fully committed to the health and safety of its workforce and to compliance with reclamation and environmental standards. No events to display. Investor related questions can be directed to:. Download our latest earnings call. Armstrong Energy Terms of Use.
Overview :: Arotech Corporation (ARTX)
Training and Simulation Division. Sep 30, 2016. View Profile ». Arotech and CEO Steven Esses Announce Early Contract Termination. Jan 3, 2017. Read Press Release ». Sign up for email alerts. Be the first to receive breaking news. Sign up today ». Dean M. Krutty. Executive Vice President, North American Operations, Acting CEO. Thomas J. Paup. Senior Vice President - Finance and Chief Financial Officer. Senior Vice President, General Counsel and Secretary. Yaakov Har-Oz has served as our Vice President and...
ARRIS - Investor Relations
ARRIS is inventing the future of content delivery from creation to consumption. Our solutions empower customers to not only solve the industry’s most pressing technological challenges, but transform the business of delivering tomorrow’s entertainment and communications experiences to millions of people around the world. Windstream Selects ARRIS Wireless Video Gateways and Set-Tops to Power Its Kinetic TV Service. ARRIS Announces Preliminary And Unaudited Second Quarter 2015 Results. 160; 0.09.
ARRIS - Investor Relations
ARRIS is inventing the future of content delivery from creation to consumption. Our solutions empower customers to not only solve the industry’s most pressing technological challenges, but transform the business of delivering tomorrow’s entertainment and communications experiences to millions of people around the world. Windstream Selects ARRIS Wireless Video Gateways and Set-Tops to Power Its Kinetic TV Service. ARRIS Announces Preliminary And Unaudited Second Quarter 2015 Results. 160; 0.23.
Investors - Arrowhead Research Corporation
Skip to main content. Company developing targeted RNAi therapeutics. Annual Reports and Proxies. Arrowhead Research Corporation is a biopharmaceutical company developing targeted RNAi therapeutics. The company is leveraging its proprietary drug delivery technologies to develop targeted drugs based on the RNA interference mechanism that efficiently silences disease-causing genes. Arrowhead technologies also enable partners to create peptide-drug conjugates that specifically home to cell types of i...